Abstract
Background & Aims: Primary biliary cholangitis (PBC) predominantly affects middle-aged women; there are few data on disease phenotypes and outcomes of PBC in men and younger patients. We investigated whether differences in sex and/or age at the start of ursodeoxycholic acid (UDCA) treatment are associated with response to therapy, based on biochemical markers, or differences in transplant-free survival. Methods: We performed a longitudinal retrospective study of 4355 adults in the Global PBC Study cohort, collected from 17 centers across Europe and North America. Patients received a diagnosis of PBC from 1961 through 2014. We evaluated the effects of sex and age on response to UDCA treatment (based on GLOBE score) and transplant-free survival using logistic regression and Cox regression analyses, respectively. Results: Male patients were older at the start of treatment (58.3±12.1 years vs 54.3±11.6 years for women; P
Author supplied keywords
Cite
CITATION STYLE
Cheung, A. C., Lammers, W. J., Murillo Perez, C. F., van Buuren, H. R., Gulamhusein, A., Trivedi, P. J., … Hansen, B. E. (2019). Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. Clinical Gastroenterology and Hepatology, 17(10), 2076-2084.e2. https://doi.org/10.1016/j.cgh.2018.12.028
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.